Alcami's new sterile fill-finish line supports vial formats from 2R to 30R, enhancing clinical and commercial manufacturing ...

In fact, according to IQVIA, 52% of the wholesale acquisition cost, which is considered one of the best approximations of the ...

In a discussion on global trade disruption, Thani Jambulingam, PhD, professor of food, pharma, and healthcare business at ...

In today’s Pharma Pulse, House Republicans block a critical insurance subsidy extension, as new research highlights the oncology benefits of GLP-1s.

CEVA Logistics' acquisition of Fagioli Group enhances its end-to-end logistics capabilities, integrating Fagioli's expertise ...

Pharmacy benefit managers (PBMs) significantly impact GTN revenue through rebates, but patient access issues persist due to ...

In today’s Pharma Pulse, Novartis and Moderna anchor a domestic manufacturing surge, while AI-driven biomarker discovery and ...

Cheryl Allen, BS Pharm, MBA, founding partner, highlights the coming year's focus on navigating an evolving regulatory ...

In today’s Pharma Pulse, SOBI strengthens its gout franchise by acquiring Arthrosi Therapeutics for up to $1.5 billion, ...

Major regulatory developments—including the Medicare MFP program, the introduction of the 340B rebate, changes to the MDRP, and updates to the physician fee schedule—are reshaping commercial ...

In mid-November, to boost domestic drug product manufacturing of its own, Moderna announced 3 a new $140 million investment ...

The evolution from time-consuming manual reviews to automated detection and now to intelligent action is reimagining the ...